The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition.
- Published in:
- Experimental Brain Research, 2017, v. 235, n. 1, p. 279, doi. 10.1007/s00221-016-4789-z
- By:
- Publication type:
- Article
Works matching DE "ASPARTOACYLASE"
Results: 16
1
2
Suppressing N-Acetyl-L-Aspartate Synthesis Prevents Loss of Neurons in a Murine Model of Canavan Leukodystrophy.
- Published in:
- Journal of Neuroscience, 2017, v. 37, n. 2, p. 413, doi. 10.1523/JNEUROSCI.2013-16.2017
- By:
- Publication type:
- Article
3
Loss of Central Auditory Processing in a Mouse Model of Canavan Disease.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0097374
- By:
- Publication type:
- Article
4
Acetate Supplementation Induces Growth Arrest of NG2/PDGFRα-Positive Oligodendroglioma-Derived Tumor-Initiating Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0080714
- By:
- Publication type:
- Article
5
Aspartoacylase-LacZ Knockin Mice: An Engineered Model of Canavan Disease.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0020336
- By:
- Publication type:
- Article
6
A novel Aspartoacylase (ASPA) Gene Mutation in Canavan Disease.
- Published in:
- Fetal & Pediatric Pathology, 2012, v. 31, n. 4, p. 236, doi. 10.3109/15513815.2011.650292
- By:
- Publication type:
- Article
7
Supercomputer technologies for structural-kinetic study of mechanisms of enzyme catalysis: A quantum-chemical description of aspartoacylase catalysis.
- Published in:
- Doklady Physical Chemistry, 2017, v. 474, n. 2, p. 89, doi. 10.1134/S0012501617060045
- By:
- Publication type:
- Article
8
Aspartoacylase supports oxidative energy metabolism during myelination.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2012, v. 32, n. 9, p. 1725, doi. 10.1038/jcbfm.2012.66
- By:
- Publication type:
- Article
9
A Single Intravenous rAAV Injection as Late as P20 Achieves Efficacious and Sustained CNS Gene Therapy in Canavan Mice.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 12, p. 2136, doi. 10.1038/mt.2013.138
- By:
- Publication type:
- Article
10
Gene Therapy for Canavan's Disease Takes a Step Forward.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 3, p. 505, doi. 10.1038/mt.2013.25
- By:
- Publication type:
- Article
11
Comparative computational assessment of the pathogenicity of mutations in the Aspartoacylase enzyme.
- Published in:
- Metabolic Brain Disease, 2017, v. 32, n. 6, p. 2105, doi. 10.1007/s11011-017-0090-5
- By:
- Publication type:
- Article
12
Investigation of the motor system in two siblings with Canavan's disease: a combined transcranial magnetic stimulation (TMS) - diffusion tensor imaging (DTI) study.
- Published in:
- Metabolic Brain Disease, 2017, v. 32, n. 2, p. 307, doi. 10.1007/s11011-017-9955-x
- By:
- Publication type:
- Article
13
Novel mutation in an Egyptian patient with infantile Canavan disease.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 3, p. 573, doi. 10.1007/s11011-015-9772-z
- By:
- Publication type:
- Article
14
Expanding the phenotype in aminoacylase 1 (ACY1) deficiency: characterization of the molecular defect in a 63-year-old woman with generalized dystonia.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 3, p. 587, doi. 10.1007/s11011-015-9778-6
- By:
- Publication type:
- Article
15
Structural modeling of p.V31F variant in the aspartoacylase gene.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 3, p. 723, doi. 10.1007/s11011-016-9796-z
- By:
- Publication type:
- Article
16
Atypical clinical and radiological course of a patient with Canavan disease.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 2, p. 475, doi. 10.1007/s11011-015-9767-9
- By:
- Publication type:
- Article